News

GSK-Backed Sitryx Launches With Six Immunometabolism Eggs In Its Basket

GlaxoSmithKline, SV Health Investors and Sofinnova are among the backers of a new Oxford-based biotech which has raised $30m in series A financing and boasts a strong line-up of academic founders. CEO Neil Weir outlines Sitryx’s raison d’etre.

View Article: https://hbw.pharmaintelligence.informa.com/SC123958/GSK-Backed-Sitryx-Launches-With-Six-Immunometabolism-Eggs-In-Its-Basket

Paul Peter Tak

© Paul Peter Tak.
All rights reserved.